Publication | Closed Access

Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman

Metabolic SyndromeHypertensionCardiovascular DiseaseMaternal Cardiovascular OutcomeDiabetesGynecologyGestational DiabetesMaternal HealthInadvertent ExposureHypertensive WomanMaternal-fetal MedicineNormal Pregnancy OutcomePublic HealthMedicineDyslipidemiaWomen's HealthHigh-risk Pregnancy